IκB kinase‐α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage‐based anticancer therapy

Authors:

Abstract
Activation of the IκB kinase (IKK) complex has recurrently been linked to colorectal cancer (CRC) initiation and progression. However, identification of downstream effectors other than NF-κB has remained elusive. Here, analysis of IKK-dependent substrates in CRC cells after UV treatment revealed that phosphorylation of BRD4 by IKK-α is required for its chromatin-binding at target genes upon DNA damage. Moreover, IKK-α induces the NF-κB-dependent transcription of the cytokine LIF, leading to STAT3 activation, association with BRD4 and recruitment to specific target genes. IKK-α abrogation results in defective BRD4 and STAT3 functions and consequently irreparable DNA damage and apoptotic cell death upon different stimuli. Simultaneous inhibition of BRAF-dependent IKK-α activity, BRD4, and the JAK/STAT pathway enhanced the therapeutic potential of 5-fluorouracil combined with irinotecan in CRC cells and is curative in a chemotherapy-resistant xenograft model. Finally, coordinated expression of LIF and IKK-α is a poor prognosis marker for CRC patients. Our data uncover a functional link between IKK-α, BRD4, and JAK/STAT signaling with clinical relevance.
Funding Information
  • Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (2017SGR135)
  • Fundación Científica Asociación Española Contra el Cáncer (POSTD21975)
  • Agència de Gestió d'Ajuts Universitaris i de Recerca (INV‐100005/100005ID5)
  • MEC | Instituto de Salud Carlos III (PI22/00069)
  • MEC | Instituto de Salud Carlos III (FI20/00130)
  • MEC | Instituto de Salud Carlos III (FI17/00047)
  • MEC | Instituto de Salud Carlos III (PT13/0001)
  • MEC | Instituto de Salud Carlos III (PT20/00023)
  • MEC | Instituto de Salud Carlos III (PI19/00318)
  • MEC | Instituto de Salud Carlos III (PI19/01320)

This publication has 60 references indexed in Scilit: